Neuronetics
Manufacturing medical devices for psychiatric and neurological disorders.
loading funding rounds…
Polaris Partners(exited)
Pfizer(exited)
Onset Ventures(exited)
New Leaf Venture Partners(exited)
Investor Growth Capital(exited)
GE Ventures(exited)
Accuitive Medical Ventures(exited)
InterWest Partners(exited)
Industry Ventures(exited)
KBL Healthcare Ventures(exited)
Partisan Management Group(exited)
Pfizer Ventures(exited)
Emory University(exited)
Quaker Partners(exited)
Cannell Capital(exited)
SLR Capital Partners(exited)
Quaker Bio Ventures(exited)
Three Arch Partners(exited)
Western Technology Investment(exited)
Ascension Ventures(exited)
Armentum Partners(exited)
Ascension(exited)
Perceptive Advisors(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 12 % | 18 % | 9 % | 5 % | 101 % | 12 % | 13 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (47 %) | (48 %) | (33 %) | (41 %) | (4 %) | 2 % | 5 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (56 %) | (57 %) | (42 %) | (58 %) | (15 %) | (8 %) | (3 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 14 % | 14 % | 13 % | 17 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Neuronetics
Edit
ACQUISITION by Neuronetics Aug 2024